Source: Virtual Congress 2020 – New tools for risk stratification of obstructive diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
K. Brat (Brno, Czech Republic), V. Koblizek (Hradec Kralove, Czech Republic), M. Svoboda (Brno, Czech Republic), M. Plutinsky (Brno, Czech Republic), J. Zatloukal (Olomouc, Czech Republic), E. Volakova (Olomouc, Czech Republic), B. Novotna (Prague, Czech Republic), P. Popelkova (Ostrava, Czech Republic), T. Dvorak (Mlada Boleslav, Czech Republic), O. Kudela (Hradec Kralove, Czech Republic), M. Kopecky (Hradec Kralove, Czech Republic), P. Musilova (Jihlava, Czech Republic), E. Kocova (Hradec Kralove, Czech Republic), P. Vanik (Ceska Budejovice, Czech Republic), L. Heribanova (Prague, Czech Republic). Phenotypes, treatable traits, GOLD groups and grades – how they predict mortality risk in COPD patients? (data from the Czech Multicenter Research Database of COPD). 3762

Member's Comments

No comment yet.

Related content which might interest you: Effect of COPD medications on exacerbation rates in a real-life COPD patient cohort - data from the Czech Multicenter Research Database of COPD. Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020 Respiratory parameters predict mortality in COPD patients - data from the Czech multicentre research database of severe COPD. Source: International Congress 2017 – Markers of COPD progression Year: 2017 Distribution and significance of GOLD 2011 disease severity classification in patients with COPD in China: A national cross-sectional survey Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 COPD-specific co-morbidity test (COTE) for predicting mortality in COPD – Results of an European, multicenter study Source: International Congress 2014 – Markers Year: 2014 Multinational, database cohort study to study mortality and risk factors of mortality in patients with asthma Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016 Mortality rates in individuals with asthma, COPD and ACOS in a large population-based cohort: Is gender important? Source: International Congress 2016 – Asthma, COPD, and ACOS: physical activity, dietary aspects, and diseases burden Year: 2016 Prevalence of comorbidities in patients with COPD: Data from the TOPDOCS cohort Source: Annual Congress 2013 –COPD: acute exacerbations and others Year: 2013 Real life distribution of the COPD patients in GOLD groups A to D in German population: DACCORD registry Source: International Congress 2014 – Rationale behind respiratory drug development Year: 2014 Comparing the 2007 and 2011 GOLD classifications as predictors of all-cause mortality and morbidity in COPD Source: International Congress 2014 – Monitoring COPD with different biomarkers Year: 2014 COPD as risk factor for mortality in CAP. Results from the German Competence Network, CAPNETZ Source: Annual Congress 2013 –COPD and infections Year: 2013 Gender differences in patients with severe asthma in real-life setting: data from the Severe Asthma Network in Italy (SANI) registry Source: International Congress 2019 – Phenotypes and comorbidities of airway diseases Year: 2019 Risk of cardiovascular events following COPD hospitalisation: Findings from the China Kadoorie Biobank cohort study Source: International Congress 2015 – COPD and lung function: risk factors and outcomes Year: 2015 Comorbidities, gender-differences and COPD severity: The French Palomb cohort Source: International Congress 2015 – Risk factors and co-morbidities in asthma and COPD Year: 2015 GOLD classifications and mortality in COPD: The HUNT study Source: Annual Congress 2013 –Investigating COPD in longitudinal studies Year: 2013 Disease progression and changes in risk groups' classification over a period of one year in the GPs based Swiss chronic obstructive pulmonary disease (COPD) cohort Source: International Congress 2014 – Diagnosis and treatment of COPD in primary care Year: 2014 Characteristics and outcomes of GOLD C and D COPD patients Source: International Congress 2014 – Longitudinal studies of respiratory disease Year: 2014 Comorbidities and COPD severity: The French Palomb cohort Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 Does Nutritional Risk Screening 2002 correlate with  dyspnea status of patients with GOLD stage 3-4 chronic obstructive pulmonary disease: a Cohort study. Source: International Congress 2018 – Nutrition and metabolic syndrome in COPD Year: 2018 Comparison of gender-related risk factors for COPD – Results from the Canadian obstructive lung disease (CanCOLD) study Source: Annual Congress 2013 –Factors associated with outcomes in COPD Year: 2013 COPD therapy based on clinical phenotypes: Baseline data from the Czech multicentre research database of COPD Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD Year: 2015